Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pharma shells out $1.2M daily on lobbying
Fierce Pharma
Monday, July 6, 2009 - 10:48am
tags:
lobbying
Why Access Pharmaceutical's MuGard Will Be Successful
Seeking Alpha
Monday, July 6, 2009 - 10:46am
tags:
MuGuard, Access Pharmaceuticals, cancer
Why it's finally time to buy Big Pharma
Stockhouse
Monday, July 6, 2009 - 10:33am
tags:
drug stocks, Big Pharma
Lilly Receives Fourth FDA Approval for ALIMTA
Yahoo
Monday, July 6, 2009 - 9:20am
tags:
Eli Lilly, FDA, Alimta, lung cancer
Sanofi’s Lantus Didn’t Raise Blindness Risk in Study
Bloomberg
Monday, July 6, 2009 - 9:16am
tags:
Sanofi, Lantus, diabetes
Spectrum Pharma lower after FDA data request
Marketwatch
Monday, July 6, 2009 - 9:12am
tags:
FDA, Spectrum Pharmaceuticals, Zevalin
Ipsen Afflicted by Too Many Drugs, Bucks Trend Infecting Others
Bloomberg
Monday, July 6, 2009 - 5:12am
tags:
Ipsen, Allergan, Botox
Dealmaking Sweeps the Biotech Sector
Seeking Alpha
Sunday, July 5, 2009 - 6:02pm
tags:
JNJ, Elan, Cell Genesys, CombinatoRx, Acorda Therapeutics, BioSante, Biogen Idec, Geron, Roche, Mylan, Wyeth
Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for Zevalin
Yahoo/AP
Sunday, July 5, 2009 - 5:58pm
tags:
Spectrum Pharmaceuticals, Zevalin, FDA
Bayer Launches New Anti-Clotting Drug in China
Seeking Alpha
Sunday, July 5, 2009 - 9:56am
tags:
Bayer, China, anti-clotting, Xarelto
Elan well worth a punt at this price
Independent,Ireland
Sunday, July 5, 2009 - 8:44am
tags:
Elan, JNJ
Isis entering a new phase
San Diego Tribune, CA
Sunday, July 5, 2009 - 8:43am
tags:
Isis Pharmaceuticals, antisense
Extreme FDA Trades: Another 18 Stocks Under 5 Bucks
Seeking Alpha
Sunday, July 5, 2009 - 8:38am
tags:
Javelin, Acrux, Arena Pharmaceuticals, Cardium, Vivus, Orexigen, Biodel, Avanir, Alexza, Acadia, GenVec, Celsion, Antigenics, Osteotech, Transdel, pSivida, ARYx, Chelsea Therapeutics, CytRx, Human Genome Sciences
A Rocky Week For Abbott Labs
Investopedia
Sunday, July 5, 2009 - 8:35am
tags:
Abbott Laboratories, JNJ, Merck, Humira
Likely FDA Approval Gives Dendreon A Lift
Yahoo/Investors Business Daily
Friday, July 3, 2009 - 10:21am
tags:
FDA, Dendreon, Provenge, prostate cancer
Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
Yahoo
Friday, July 3, 2009 - 10:15am
tags:
JNJ, Cougar Biotechnology, buyouts
Novo Hopes Victoza’s EU Clearance Bodes Well for US
InVivo
Friday, July 3, 2009 - 8:42am
tags:
Victoza, EU, Europe, Novo Nordisk
Four Must-See Charts: Stem Cell Stocks
TheStreet.com
Friday, July 3, 2009 - 8:40am
tags:
stem cells, Geron, Life Technologies, Osiris Therapeutics, Aastrom, Neuralstem
Study of Sepracor’s Depression Drug Has Investors Gloomy
Seeking Alpha
Friday, July 3, 2009 - 8:38am
tags:
Sepracor, depression, drug trials
Tamiflu-Resistant Swine Flu Virus Found in Hong Kong
Bloomberg
Friday, July 3, 2009 - 8:37am
tags:
Hong Kong, Roche, Tamiflu, swine flu, H1N1

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.